Literature DB >> 30888482

Usefulness of the inchworm sign on DWI for predicting pT1 bladder cancer progression.

Shugo Yajima1, Soichiro Yoshida2, Taro Takahara3, Yuki Arita4, Hiroshi Tanaka5, Yuma Waseda1, Minato Yokoyama1, Junichiro Ishioka1, Yoh Matsuoka1, Kazutaka Saito1, Kazunori Kihara1, Yasuhisa Fujii1.   

Abstract

OBJECTIVE: To evaluate the significance of the presence or absence of an "inchworm sign" on DWI for the recurrence and progression of T1 bladder cancer.
MATERIALS AND METHODS: We retrospectively analyzed 91 patients with pT1 urothelial carcinoma who underwent DWI prior to transurethral resection between 2007 and 2016. DWI of the dominant tumors was scrutinized for inchworm signs at b = 1000 s/mm2. The association of the presence of the inchworm sign with progression and recurrence was analyzed; progression was defined as recurrence to stage T2 or higher and/or N+, and/or M1.
RESULTS: An inchworm sign was seen in 65 cases (71%), while it was absent in 26 cases. Among the 65, 25 (38%) had confirmed tumor recurrence, while in the remaining 26, 14 (54%) had confirmed recurrence (median time post TURB = 7.9 and 10.1 months for each). At the time of recurrence, the tumor had progressed in one (2%) inchworm-sign-positive and seven (27%) inchworm-sign-negative cases. The progression rate of inchworm-sign-negative cases was significantly higher than that of inchworm-sign-positive cases (hazard ratio = 17.2, p = 0.0017), whereas there was no significant difference in the recurrence rate between two groups. The absence of an inchworm sign and histological grade 3 were independent risk factors for progression (p < 0.001 and 0.010, respectively).
CONCLUSIONS: The absence of an inchworm sign on DWI was a significant prognostic factor for progression of T1 bladder cancer. Morphological evaluation of DWI signals may therefore be a useful adjunct to preoperative assessment of biological aggressiveness. KEY POINTS: • An inchworm sign is a simple diagnostic criterion that characterizes only the shape of the tumor signal on DWI, and potentially serves as an imaging biomarker to predict clinical aggressiveness. • The absence of an inchworm sign on DWI is a significant indicator of progression of T1 bladder cancer.

Entities:  

Keywords:  Biomarkers; Diffusion magnetic resonance imaging; Magnetic resonance imaging; Prognosis; Urinary bladder neoplasms

Mesh:

Year:  2019        PMID: 30888482     DOI: 10.1007/s00330-019-06119-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  25 in total

1.  Is microstaging of early invasive cancer of the urinary bladder possible or useful?

Authors:  C E Platz; M B Cohen; M P Jones; D B Olson; C F Lynch
Journal:  Mod Pathol       Date:  1996-11       Impact factor: 7.842

2.  The value of diffusion-weighted MRI in the diagnosis of malignant and benign urinary bladder lesions.

Authors:  S Avcu; M N Koseoglu; K Ceylan; M D Bulut; M Dbulutand; O Unal
Journal:  Br J Radiol       Date:  2011-01-11       Impact factor: 3.039

3.  Predicting cancer progression in patients with stage T1 bladder carcinoma.

Authors:  L Cheng; R M Neumann; A L Weaver; B E Spotts; D G Bostwick
Journal:  J Clin Oncol       Date:  1999-10       Impact factor: 44.544

4.  EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

Authors:  Marko Babjuk; Andreas Böhle; Maximilian Burger; Otakar Capoun; Daniel Cohen; Eva M Compérat; Virginia Hernández; Eero Kaasinen; Joan Palou; Morgan Rouprêt; Bas W G van Rhijn; Shahrokh F Shariat; Viktor Soukup; Richard J Sylvester; Richard Zigeuner
Journal:  Eur Urol       Date:  2016-06-17       Impact factor: 20.096

Review 5.  DWI as an Imaging Biomarker for Bladder Cancer.

Authors:  Soichiro Yoshida; Taro Takahara; Thomas C Kwee; Yuma Waseda; Shuichiro Kobayashi; Yasuhisa Fujii
Journal:  AJR Am J Roentgenol       Date:  2017-02-28       Impact factor: 3.959

6.  Usefulness of diffusion-weighted MRI in diagnosis of upper urinary tract cancer.

Authors:  Soichiro Yoshida; Hitoshi Masuda; Chikako Ishii; Hiroshi Tanaka; Yasuhisa Fujii; Satoru Kawakami; Kazunori Kihara
Journal:  AJR Am J Roentgenol       Date:  2011-01       Impact factor: 3.959

7.  Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness.

Authors:  Shuichiro Kobayashi; Fumitaka Koga; Soichiro Yoshida; Hitoshi Masuda; Chikako Ishii; Hiroshi Tanaka; Yoshinobu Komai; Minato Yokoyama; Kazutaka Saito; Yasuhisa Fujii; Satoru Kawakami; Kazunori Kihara
Journal:  Eur Radiol       Date:  2011-06-18       Impact factor: 5.315

8.  Analysis of bladder carcinoma by subsite. Cystoscopic location may have prognostic value.

Authors:  W T Stephenson; F F Holmes; M J Noble; K B Gerald
Journal:  Cancer       Date:  1990-10-01       Impact factor: 6.860

9.  Significance of bladder neck involvement on progression in superficial bladder cancer.

Authors:  Y Fujii; I Fukui; K Kihara; T Tsujii; K Ishizaka; Y Kageyama; S Kawakami; H Oshima
Journal:  Eur Urol       Date:  1998       Impact factor: 20.096

10.  Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade.

Authors:  Mitsuru Takeuchi; Shigeru Sasaki; Masato Ito; Shinsuke Okada; Satoru Takahashi; Tatsuya Kawai; Kaori Suzuki; Hidekazu Oshima; Masaki Hara; Yuta Shibamoto
Journal:  Radiology       Date:  2009-04       Impact factor: 11.105

View more
  2 in total

1.  A predictive nomogram for individualized recurrence stratification of bladder cancer using multiparametric MRI and clinical risk factors.

Authors:  Xiaopan Xu; Huanjun Wang; Peng Du; Fan Zhang; Shurong Li; Zhongwei Zhang; Jing Yuan; Zhengrong Liang; Xi Zhang; Yan Guo; Yang Liu; Hongbing Lu
Journal:  J Magn Reson Imaging       Date:  2019-04-13       Impact factor: 4.813

Review 2.  Study Progress of Noninvasive Imaging and Radiomics for Decoding the Phenotypes and Recurrence Risk of Bladder Cancer.

Authors:  Xiaopan Xu; Huanjun Wang; Yan Guo; Xi Zhang; Baojuan Li; Peng Du; Yang Liu; Hongbing Lu
Journal:  Front Oncol       Date:  2021-07-15       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.